Technology Overload: Addressing Site Challenges of Digital Trials

Featured speakers dive into the site experience and discuss the importance of implementing a change in management strategy coupled with a unified digital trial platform that streamlines eConsent, eCOA, sensors and integration workflows into a single end-to-end experience.

Register Free: https://www.biopharminternational.com/bp_w/technology-overload

Event Overview:

While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies is overwhelming sites. To run one clinical trial, the investigative site team can use up to 40 different systems (EDC, EHR/EMR, payments, CTMS, radiology, technology vendors, etc.) while also learning to leverage remote site staff and virtual facilities. While technology should, in theory, make sites’ operations easier, the surplus of distinct point solutions can create burdens.

In this webcast, featured speakers will dive into the site experience and discuss the importance of implementing a change management strategy coupled with a unified digital trial platform that streamlines eConsent, eCOA, sensors and integration workflows into a single end-to-end experience. This will ensure productive sites that can focus on participants.

Key Learning Objectives

• Site pain points associated with digital trials (lack of flexibility, autonomy, and budget)
• Guidelines to ensure the optimal combination of technologies for sites
• Effective change management tactics to make sites comfortable with new technologies
• A case study of effective digital trial implementation to maximize site productivity
• Sponsor of Choice: Empowering Sites with a Voice

Who Should Attend

• Large Pharma, Biotechs, & CROs
• Clinical IT, Business IT, Clinical Operations/Research/Development, Study Management, Therapeutic Area Leads, Portfolio Leads, Innovation Leads, Procurement Leads, Science Teams, Medical Affairs, Data Management/Analysis/Process, Regulatory Affairs Heads, QA/QC, R&D, Chief Medical/Scientific Officers, Patient-centric Titles

Speakers:

Camila Matheny
Executive Director, DCT Offerings
Medable

An expert in clinical trial operations, Camila works closely with pharma, biotech, and CRO customers to articulate the value of adopting digital technologies to deliver decentralized and hybrid clinical trials. As a member of the SCDM eSource Consortium, DTRA, and EFGCP, Camila leads with data, the driving force behind bringing new therapies to market. With over 15 years of clinical trials experience, a background in data management, and a passion for the latest cutting-edge technologies, Camila provides a unique combination of expertise to help guide the industry towards the future state of patient-first clinical trials.

Katie Madden
Senior Manager, Digital and Process Optimization
GSK

As a Project Management Professional (PMP) and a Senior Manager within Digital, Analytics, and Performance, Katie is focused on the delivery of Digital Health technology within Clinical Operations. With over 10 years in the industry, Katie has front-line experience in trial delivery, intimate-knowledge of various trial supporting technology, and decentralized trials. Katie is currently, committed to ensuring that the process for asset teams to deploy novel and innovative, digital designs and features, is a paved road with a focus on agility, compliance, ethics, and safety. Katie is a published author as well as a Strategic Owner for an initiative that was a 2022 Reuters award winner for Most Valuable Digital Patient Engagement.

Alisha Lutat
Patient & Site Regional Adoption Lead
Medable

Alisha has over 15 years of hands-on patient experience in the clinical research industry and started her career as a site coordinator and progressed from that role to management roles across multiple sites. She has worked across all clinical study phases and multiple therapeutic areas with a specific focus on women's health. Prior to joining Medable, Alisha has worked in a variety of site settings, including non-profits, private practices, and, most recently, integrated research organizations, where she established Elligo's first women's health sites in Austin, Texas. In 2020, Alisha supported the landmark Moderna vaccine trials in Laredo, Texas. Currently, her primary focus at Medable remains on assisting sites with new technology, as well as bringing the voice of sites into the development and adoption of technology.

Register Free: https://www.biopharminternational.com/bp_w/technology-overload